Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C45H74O17 |
Molecular Weight | 887.0589 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 27 / 27 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@]5([H])C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@]6(CC[C@H](C)CO6)O2)O[C@]7([H])O[C@H](CO)[C@@H](O[C@]8([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@]9([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O
InChI
InChIKey=BCUDKRWNGQAFLF-PJFZGHSASA-N
InChI=1S/C45H74O17/c1-19-8-13-45(55-18-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-42-39(61-41-36(53)34(51)32(49)28(16-46)58-41)37(54)38(29(17-47)59-42)60-40-35(52)33(50)31(48)21(3)56-40/h19-42,46-54H,6-18H2,1-5H3/t19-,20-,21-,22+,23-,24+,25-,26-,27-,28+,29+,30-,31-,32+,33+,34-,35+,36+,37-,38+,39+,40-,41-,42+,43-,44-,45+/m0/s1
Molecular Formula | C45H74O17 |
Molecular Weight | 887.0589 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 26 / 27 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23248403
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403
Asparanin B is a steroidal saponin from the roots of Asparagus racemosus. It has being shown to exhibit significant anticancer activity in both in vitro and in vivo experimental models.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL387 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403 |
|||
Target ID: CHEMBL384 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403 |
|||
Target ID: CHEMBL614516 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403
250 and 500 mg/kg b.wt., orally, once daily for 10 days
Route of Administration:
Unknown
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23248403
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:58:25 GMT 2023
by
admin
on
Sat Dec 16 07:58:25 GMT 2023
|
Record UNII |
Z905922Y1P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
84633-34-1
Created by
admin on Sat Dec 16 07:58:25 GMT 2023 , Edited by admin on Sat Dec 16 07:58:25 GMT 2023
|
PRIMARY | |||
|
441896
Created by
admin on Sat Dec 16 07:58:25 GMT 2023 , Edited by admin on Sat Dec 16 07:58:25 GMT 2023
|
PRIMARY | |||
|
Z905922Y1P
Created by
admin on Sat Dec 16 07:58:25 GMT 2023 , Edited by admin on Sat Dec 16 07:58:25 GMT 2023
|
PRIMARY | |||
|
DTXSID501317487
Created by
admin on Sat Dec 16 07:58:25 GMT 2023 , Edited by admin on Sat Dec 16 07:58:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
The spirostanol glycoside-caused 100% immobilization-of human spermatozoa at 1.5%-level.
|